Akio Ido

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Gut · 2019 · 723 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda et al. · Hepatology · 2014 · 539 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

Takeshi Hori, Kenji Nagata, Satoru Hasuike et al. · Journal of Gastroenterology · 2003 · 230 citations

Medicine, Oncology, Surgery +16

Etoposide Prevents Apoptosis in Mouse Liver With D–Galactosamine/Lipopolysaccharide–Induced Fulminant Hepatic Failure Resulting in Reduction of Lethality

Tetsufumi Nakama, Shuichi Hirono, Akihiro Moriuchi et al. · Hepatology · 2001 · 160 citations · Full text

Veterinary Medicine, Pathobiology, Pharmacology +17